Acadia Healthcare Company Inc (ACHC) Receives Consensus Recommendation of “Buy” from Analysts

Acadia Healthcare Company Inc (NASDAQ:ACHC) has been given an average recommendation of “Buy” by the eighteen research firms that are presently covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $44.58.

ACHC has been the topic of a number of analyst reports. Cantor Fitzgerald reduced their price objective on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating on the stock in a report on Tuesday, October 24th. Citigroup reduced their price objective on shares of Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating on the stock in a report on Wednesday, October 25th. Craig Hallum restated a “buy” rating and issued a $41.00 price objective (down from $65.00) on shares of Acadia Healthcare in a report on Thursday, October 26th. Robert W. Baird restated a “hold” rating and issued a $37.00 price objective on shares of Acadia Healthcare in a report on Friday, December 15th. Finally, Deutsche Bank lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating and reduced their price objective for the company from $60.00 to $37.00 in a report on Wednesday, October 25th.

Shares of Acadia Healthcare (NASDAQ ACHC) opened at $34.24 on Wednesday. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $54.34. The firm has a market cap of $2,964.18, a price-to-earnings ratio of 17.38, a PEG ratio of 1.14 and a beta of 0.85. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36.

In related news, Director Reeve B. Waud sold 100,000 shares of Acadia Healthcare stock in a transaction on Friday, December 15th. The shares were sold at an average price of $31.80, for a total transaction of $3,180,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 11.10% of the stock is owned by company insiders.

A number of large investors have recently made changes to their positions in ACHC. State of Alaska Department of Revenue acquired a new stake in Acadia Healthcare during the 4th quarter worth $150,000. Rathbone Brothers plc acquired a new position in Acadia Healthcare in the third quarter valued at $223,000. CIBC World Markets Inc. acquired a new position in Acadia Healthcare in the fourth quarter valued at $236,000. Arthur Zaske & Associates LLC acquired a new position in Acadia Healthcare in the third quarter valued at $283,000. Finally, Oakbrook Investments LLC acquired a new position in Acadia Healthcare in the third quarter valued at $291,000.

TRADEMARK VIOLATION WARNING: This piece was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/14/acadia-healthcare-company-inc-achc-receives-consensus-recommendation-of-buy-from-analysts.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply